Eugene Holuka
Fortune : 57 $ au 30/06/2026
Fortune : 57 $ au 30/06/2026
Eugene Myron Holuka currently holds the positions of Independent Director at Citius Pharmaceuticals, Inc. since 2016, Medical Director at Bay Street Health Center, Independent Director at Citius Oncology, Inc. since 2024, and Associate Professor at Zucker School of Medicine.
The education history includes a doctorate degree from Universidad del Noreste AC.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/02/2026 | 95 ( 0 % ) | 57 $ | 30/06/2026 | |
-.--% | 22/05/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CITIUS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/06/2016 |
Bay Street Health Center | Corporate Officer/Principal | - |
Zucker School of Medicine
Zucker School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Operates as a pharmaceutical company | Health Technology |
Universidad del Noreste AC
Universidad del Noreste AC Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bay Street Health Center | |
Zucker School of Medicine
Zucker School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national